IGM BIOSCIENCES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.48 USD | -1.56% |
|
+19.10% | +14.08% |
| 17/04 | IGM Biosciences, Sanofi Narrow Partnership to Focus on Potential Immunology and Inflamation Targets | MT |
| 17/04 | IGM Biosciences, Inc. Announces Refocusing of Sanofi Collaboration | CI |
Chart calendar IGM Biosciences, Inc.
4bcafd13.Z_oh0Xyv6Wfz_zgC0UtzTUgc_cJ7t1O8Px461Z1zCWE.M8IXlAj-u1aEzX0xuw8JASpxkKUshGXNe2RSnfI1SAs4vVeOF8GmU4aMbQ~ea663549358bcf481a715b03851e33f1
Upcoming events on IGM Biosciences, Inc.
Past events on IGM Biosciences, Inc.
| 17/04/2024 09:30 pm | Stifel Virtual Targeted Oncology Days Conference - Fireside Chat |
| 08/03/2024 02:40 am | Q4 2023 Earnings Release |
| 09/02/2024 01:00 am | Guggenheim Healthcare Talks Biotechnology Conference |
| 11/01/2024 12:45 am | JPMorgan Healthcare Conference |
| 16/11/2023 02:30 pm | Jefferies London Healthcare Conference |
| 15/11/2023 12:55 am | Stifel Healthcare Conference |
| 14/11/2023 02:40 am | Q3 2023 Earnings Release |
| 13/09/2023 07:00 pm | Morgan Stanley Global Healthcare Conference |
| 04/08/2023 01:40 am | Q2 2023 Earnings Release |
| 23/06/2023 08:30 pm | Annual General Meeting |
| 08/06/2023 11:00 pm | Jefferies Global Healthcare Conference |
| 03/06/2023 04:30 am | IGM-8444 Clinical Update Call |
| 17/05/2023 08:30 pm | RBC Global Healthcare Conference |
| 12/05/2023 06:35 pm | Q1 2023 Earnings Release |
| 10/05/2023 04:10 am | Bank of America Healthcare Conference |
| 27/04/2023 12:30 am | Stifel Targeted Oncology Days |
| 19/04/2023 06:30 pm | American Association for Cancer Research Meeting - Poster No 6123 |
| 18/04/2023 11:00 pm | American Association for Cancer Research Meeting - Poster No 5660 |
| 18/04/2023 06:30 pm | American Association for Cancer Research Meeting - Poster No 4120 |
| 17/04/2023 11:00 pm | American Association for Cancer Research Meeting - Poster No 2959 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 1,07 16,0 -93.31% | 2,13 2,36 -9.71% | 3,04 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -161 -170 5.14% | -222 -241 8.1% | -255 -262 2.57% | -211 |
|
EBIT Million USD | Released Forecast Spread | -44,5 -42,2 -5.51% | -83,3 -84,9 1.89% | -165 -167 1.27% | -228 -241 5.46% | -263 -265 0.71% | -212 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -43,1 -40,4 -6.73% | -81,4 -83,4 2.47% | -165 -166 0.56% | -221 -236 6.36% | -246 -249 1.32% | -199 |
|
Net income Million USD | Released Forecast Spread | -43,1 -40,4 -6.73% | -81,4 -83,4 2.47% | -165 -166 0.56% | -221 -220 -0.42% | -246 -250 1.45% | -200 |
|
EPS USD | Released Forecast Spread | -4,80 -3,01 -59.47% | -2,65 -2,73 2.78% | -4,93 -4,97 0.78% | -5,32 -5,31 -0.18% | -4,71 -4,81 2.12% | -3,25 |
| Announcement Date | 26/03/20 | 30/03/21 | 29/03/22 | 30/03/23 | 07/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,37 38,9 -99.06% | 0,33 0,26 26.82% | 0,37 15,3 -97.56% | 0,52 1,31 -60.27% | 0,45 0,79 -43.22% | 0,51 0,81 -37.38% | 0,65 0,77 -15.05% | 0,76 | 0,78 | 0,82 | 0,85 |
|
EBITDA Million USD | Released Forecast Spread | -54,4 80,0 -167.96% | -66,0 -68,0 2.84% | -64,5 -72,2 10.68% | ||||||||||
|
EBIT Million USD | Released Forecast Spread | -50,7 -52,3 3.08% | -52,0 -55,9 7.1% | -59,2 -19,6 -202.46% | -60,5 -64,4 6.03% | -56,3 -69,3 18.76% | -63,9 -61,5 -3.91% | -68,2 -66,7 -2.23% | -66,8 -69,6 4.08% | -65,1 -67,8 3.99% | -53,7 | -52,2 | -52,7 | -53,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -50,6 -51,6 1.78% | -51,9 -56,3 7.76% | -58,6 -13,4 -337.6% | -58,0 -63,7 8.84% | -52,6 -48,8 -7.83% | -59,2 -59,2 -0.09% | -64,3 -63,9 -0.63% | -61,7 -65,5 5.68% | -60,5 -63,8 5.29% | -50,7 | -48,7 | -49,5 | -50,3 |
|
Net income Million USD | Released Forecast Spread | -50,6 -51,6 1.78% | -51,9 -56,3 7.76% | -58,6 -13,9 -320.47% | -58,0 -63,8 9.04% | -52,6 -51,6 -1.84% | -59,3 -59,7 0.64% | -64,4 -63,9 -0.8% | -62,0 -65,9 5.88% | -60,7 -64,6 5.99% | -50,7 | -49,1 | -49,7 | -50,4 |
|
EPS USD | Released Forecast Spread | -1,50 -1,54 2.42% | -1,53 -1,68 8.66% | -1,33 -0,40 -233.69% | -1,32 -1,45 9.12% | -1,19 -1,20 0.92% | -1,33 -1,34 1.01% | -1,43 -1,44 0.4% | -1,04 -1,26 17.4% | -1,01 -1,09 7.12% | -0,85 | -0,82 | -0,82 | -0,78 |
| Announcement Date | 29/03/22 | 09/05/22 | 08/08/22 | 03/11/22 | 30/03/23 | 12/05/23 | 03/08/23 | 13/11/23 | 07/03/24 | - | - | - | - |
| Today 03:30 pm | AURINIA PHARMACEUTICALS INC.: Q1 2024 Earnings Release |
| Today 04:00 pm | SPRINGWORKS THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| Today 04:00 pm | REGENERON PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| Today 04:30 pm | AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| Today 08:30 pm | GENMAB A/S: Q1 2024 Earnings Release |
| Today 01:31 am | ASCENDIS PHARMA A/S: Q1 2024 Earnings Release |
| 06/05/2024 | FRAZIER LIFESCIENCES ACQUISITION CORPORATION: Q1 2024 Earnings Release (Projected) |
| 06/05/2024 | KRYSTAL BIOTECH, INC.: Q1 2024 Earnings Release |
| 06/05/2024 | MERUS N.V.: Q1 2024 Earnings Release (Projected) |
| 06/05/2024 | VAXCYTE, INC.: Q1 2024 Earnings Release (Projected) |
Past sector events for IGM Biosciences, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- IGMS Stock
- Calendar IGM Biosciences, Inc.
